Cargando…

The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus

Human phospholipid scramblase 1 (PLSCR1) is strongly expressed in response to interferon (IFN) treatment and viral infection, and it has been suggested to play an important role in IFN-dependent antiviral responses. In this study, we showed that the levels of human cytomegalovirus (HCMV) plaque form...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadanari, Hidetaka, Takemoto, Masaya, Ishida, Tomoki, Otagiri, Hikaru, Daikoku, Tohru, Murayama, Tsugiya, Kusano, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826943/
https://www.ncbi.nlm.nih.gov/pubmed/35138119
http://dx.doi.org/10.1128/spectrum.01342-21
_version_ 1784647529447555072
author Sadanari, Hidetaka
Takemoto, Masaya
Ishida, Tomoki
Otagiri, Hikaru
Daikoku, Tohru
Murayama, Tsugiya
Kusano, Shuichi
author_facet Sadanari, Hidetaka
Takemoto, Masaya
Ishida, Tomoki
Otagiri, Hikaru
Daikoku, Tohru
Murayama, Tsugiya
Kusano, Shuichi
author_sort Sadanari, Hidetaka
collection PubMed
description Human phospholipid scramblase 1 (PLSCR1) is strongly expressed in response to interferon (IFN) treatment and viral infection, and it has been suggested to play an important role in IFN-dependent antiviral responses. In this study, we showed that the levels of human cytomegalovirus (HCMV) plaque formation in OUMS-36T-3 (36T-3) cells with high basal expression of PLSCR1 were significantly lower than those in human embryonic lung (HEL) cells with low basal expression of PLSCR1. In addition, the levels of HCMV plaque formation and replication in PLSCR1-knockout (KO) 36T-3 cells were significantly higher than those in parental 36T-3 cells and were comparable to those in HEL cells. Furthermore, compared to that in PLSCR1-KO cells, the expression of HCMV major immediate early (MIE) proteins was repressed and/or delayed in parental 36T-3 cells after HCMV infection. We also showed that PLSCR1 expression decreased the levels of the cAMP-responsive element (CRE)-binding protein (CREB)•HCMV immediate early protein 2 (IE2) and CREB-binding protein (CBP)•IE2 complexes, which have been suggested to play important roles in the IE2-mediated transactivation of the viral early promoter through interactions with CREB, CBP, and IE2. Interestingly, PLSCR1 expression repressed CRE- and HCMV MIE promoter-regulated reporter gene activities. These observations reveal, for the first time, that PLSCR1 negatively regulates HCMV replication by repressing the transcription from viral MIE and early promoters, and that PLSCR1 expression may contribute to the IFN-mediated suppression of HCMV infection. IMPORTANCE Because several IFN-stimulated genes (ISGs) have been reported to suppress HCMV replication, HCMV replication is thought to be regulated by an IFN-mediated host defense mechanism, but the mechanism remains unclear. PLSCR1 expression is induced in response to viral infection and IFN treatment, and PLSCR1 has been reported to play an important role in IFN-dependent antiviral responses. Here, we demonstrate that HCMV plaque formation and major immediate early (MIE) gene expression are significantly increased in PLSCR1-KO human fibroblast cells. PLSCR1 reduces levels of the CREB•IE2 and CBP•IE2 complexes, which have been suggested to play important roles in HCMV replication through its interactions with CREB, CBP, and IE2. In addition, PLSCR1 expression represses transcription from the HCMV MIE promoter. Our results indicate that PLSCR1 plays important roles in the suppression of HCMV replication in the IFN-mediated host defense system.
format Online
Article
Text
id pubmed-8826943
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-88269432022-02-17 The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus Sadanari, Hidetaka Takemoto, Masaya Ishida, Tomoki Otagiri, Hikaru Daikoku, Tohru Murayama, Tsugiya Kusano, Shuichi Microbiol Spectr Research Article Human phospholipid scramblase 1 (PLSCR1) is strongly expressed in response to interferon (IFN) treatment and viral infection, and it has been suggested to play an important role in IFN-dependent antiviral responses. In this study, we showed that the levels of human cytomegalovirus (HCMV) plaque formation in OUMS-36T-3 (36T-3) cells with high basal expression of PLSCR1 were significantly lower than those in human embryonic lung (HEL) cells with low basal expression of PLSCR1. In addition, the levels of HCMV plaque formation and replication in PLSCR1-knockout (KO) 36T-3 cells were significantly higher than those in parental 36T-3 cells and were comparable to those in HEL cells. Furthermore, compared to that in PLSCR1-KO cells, the expression of HCMV major immediate early (MIE) proteins was repressed and/or delayed in parental 36T-3 cells after HCMV infection. We also showed that PLSCR1 expression decreased the levels of the cAMP-responsive element (CRE)-binding protein (CREB)•HCMV immediate early protein 2 (IE2) and CREB-binding protein (CBP)•IE2 complexes, which have been suggested to play important roles in the IE2-mediated transactivation of the viral early promoter through interactions with CREB, CBP, and IE2. Interestingly, PLSCR1 expression repressed CRE- and HCMV MIE promoter-regulated reporter gene activities. These observations reveal, for the first time, that PLSCR1 negatively regulates HCMV replication by repressing the transcription from viral MIE and early promoters, and that PLSCR1 expression may contribute to the IFN-mediated suppression of HCMV infection. IMPORTANCE Because several IFN-stimulated genes (ISGs) have been reported to suppress HCMV replication, HCMV replication is thought to be regulated by an IFN-mediated host defense mechanism, but the mechanism remains unclear. PLSCR1 expression is induced in response to viral infection and IFN treatment, and PLSCR1 has been reported to play an important role in IFN-dependent antiviral responses. Here, we demonstrate that HCMV plaque formation and major immediate early (MIE) gene expression are significantly increased in PLSCR1-KO human fibroblast cells. PLSCR1 reduces levels of the CREB•IE2 and CBP•IE2 complexes, which have been suggested to play important roles in HCMV replication through its interactions with CREB, CBP, and IE2. In addition, PLSCR1 expression represses transcription from the HCMV MIE promoter. Our results indicate that PLSCR1 plays important roles in the suppression of HCMV replication in the IFN-mediated host defense system. American Society for Microbiology 2022-02-09 /pmc/articles/PMC8826943/ /pubmed/35138119 http://dx.doi.org/10.1128/spectrum.01342-21 Text en Copyright © 2022 Sadanari et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Sadanari, Hidetaka
Takemoto, Masaya
Ishida, Tomoki
Otagiri, Hikaru
Daikoku, Tohru
Murayama, Tsugiya
Kusano, Shuichi
The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus
title The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus
title_full The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus
title_fullStr The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus
title_full_unstemmed The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus
title_short The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus
title_sort interferon-inducible human plscr1 protein is a restriction factor of human cytomegalovirus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826943/
https://www.ncbi.nlm.nih.gov/pubmed/35138119
http://dx.doi.org/10.1128/spectrum.01342-21
work_keys_str_mv AT sadanarihidetaka theinterferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT takemotomasaya theinterferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT ishidatomoki theinterferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT otagirihikaru theinterferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT daikokutohru theinterferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT murayamatsugiya theinterferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT kusanoshuichi theinterferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT sadanarihidetaka interferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT takemotomasaya interferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT ishidatomoki interferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT otagirihikaru interferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT daikokutohru interferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT murayamatsugiya interferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus
AT kusanoshuichi interferoninduciblehumanplscr1proteinisarestrictionfactorofhumancytomegalovirus